Evidence record 16122 · automatically gathered

CellPrism: A Visual Analytics System for Exploring AI-Driven Virtual Cells in Drug Discovery

Gene perturbation analysis plays a critical role in drug discovery by enabling researchers to investigate how interventions on specific genes influence global gene expression patterns within cells. Recent advances in artificial intelligence-driven virtual cell models have made it possible to predict gene expression outcomes for a wide range of perturbation strategies in silico, substantially reducing reliance on costly and time-consuming biological experiments. However, effectively exploring and

Record details

Published: 3 August 2026
Source: arXiv cs.HC
Category: Research
Topics: Healthcare · Finance, VC & PE · Biotech
Retrieved: 4 August 2026

source-onlyevidence status

These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.

How to cite this record

ethics.ai (3 August 2026), “CellPrism: A Visual Analytics System for Exploring AI-Driven Virtual Cells in Drug Discovery,” evidence record 16122, https://ethics.ai/record/16122 (originally published by arXiv cs.HC).

JSON

Use and limitations

This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.